This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Peptides & Oligonucleotides
Drug Manufacturing

Innovations by PeptiStar for Middlemolecule Drug Substance Manufacturing

Posted by on 27 January 2022
Share this article

PeptiStar is a peptide CDMO in Japan, which has unique & innovative peptide manufacturing technologies and state-of-the-art cGMP manufacturing facilities. In this article, we introduce 1. a series of the world’s first technologies for peptide manufacturing developed by PeptiStar and its partners and 2. PeptiStar’s new capabilities of oligonucleotide manufacturing.

  1. PeptiStar has successfully made innovations in each step of peptide manufacturing: (i) Synthesis - SYNCSOLTM (coupling reactions using unprotected amino acids), (ii) Purification – continuous chromatography (achieving high quality and high recovery rate simultaneously), (iii) Concentration – new membrane concentration method (high efficiency without a heat or pressure load), and (iv) Drying – new freeze-drying method (reducing processing time by >80%).
  2. Last but not least, we also discuss PeptiStar’s new capabilities in oligonucleotide manufacturing.

Download the full whitepaper by simply hitting the 'Download Now' link at the top of the page.

Share this article